RxDoctor Payments Data

Suzanne Kelly, DO

Family Medicine · Doylestown, PANPI 1275705485

Payments from drug & device makers

$1,566in general payments, 2019–2025

Across 83 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$343
  • Pfizer$204
  • Novo Nordisk$173
  • GSK$137
  • AstraZeneca$128
  • Lilly USA, LLC$122
  • plus $459 from 15 others

What the payments were for

  • Food & beverage$1,566100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,566 in reported general payments places this provider in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$177,706
Medicare patients
348
Services billed
2,361

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide52$52,272
EliquisApixaban56$46,503
OzempicSemaglutide33$37,930
JardianceEmpagliflozin27$36,753
MyrbetriqMirabegron34$26,252
TrulicityDulaglutide20$19,177
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$15,558
FarxigaDapagliflozin Propanediol11$7,747
QuviviqDaridorexant Hcl11$5,224
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,176
SynthroidLevothyroxine Sodium55$4,505
Levothyroxine Sodium350$4,339
Novolog FlexpenInsulin Aspart12$3,305
Arnuity ElliptaFluticasone Furoate16$3,296
Rosuvastatin Calcium240$3,288

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$122$71,44972 claims
PfizerEliquis, Paxlovid$204$47,93371 claims
Novo NordiskOzempic$173$37,93033 claims
Boehringer IngelheimJardiance$47$36,75327 claims
Astellas Pharma US IncMyrbetriq$15$26,25234 claims
GSKTrelegy Ellipta, Anoro Ellipta, Arnuity Ellipta$137$24,03047 claims
AstraZenecaFarxiga, Symbicort$128$9,82323 claims
AbbVieSynthroid$343$4,50555 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Doylestown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →